Search research articles
Contact Us
Filters
Showing results (61-70 of 326) with videos related to
Page
of 33
Sort By:
Cancer Treatment Reports
|
February 1, 1980
Phase II evaluation of N-(phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma
D S Carroll, R J Gralla, N E Kemeny
Cancer Research
|
June 1, 1981
Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule
E S Casper, R J Gralla, C W Young
Cancer Treatment Reports
|
October 1, 1978
Phase II evaluation of pyrazofurin in patients with metastatic sarcoma
R J Gralla, P P Sordillo, G B Magill
Food and Cosmetics Toxicology
|
February 1, 1977
Preliminary neurological evaluation of generalized weakness in zinc pyrithione-treated rats
D R Snyder, E J Gralla, G L Coleman
Supportive Cancer Therapy
|
July 18, 2008
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis
G Kesava Reddy, Richard J Gralla, Paul J Hesketh
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Vindesine. A review of phase-II trials
R J Gralla, C T Tan, C W Young
Cancer Chemotherapy Reports. Part 3
|
September 1, 1974
Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug
E J Gralla, G L Coleman, A M Jonas
Cancer Treatment Reports
|
December 1, 1982
High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial
L B Tyson, R A Clark, R J Gralla
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 29, 2010
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference
Fausto Roila, Jorn Herrstedt, Richard J Gralla, et al.
Cancer Treatment Reports
|
January 1, 1979
Phase I trial of chlorozotocin
R J Gralla, C T Tan, C W Young
Page
of 33
Search research articles
Search
Showing results (61-70 of 326) with videos related to
Sort By:
Page
of 33
Cancer Treatment Reports
|
February 1, 1980
Phase II evaluation of N-(phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma
D S Carroll, R J Gralla, N E Kemeny
Cancer Research
|
June 1, 1981
Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule
E S Casper, R J Gralla, C W Young
Cancer Treatment Reports
|
October 1, 1978
Phase II evaluation of pyrazofurin in patients with metastatic sarcoma
R J Gralla, P P Sordillo, G B Magill
Food and Cosmetics Toxicology
|
February 1, 1977
Preliminary neurological evaluation of generalized weakness in zinc pyrithione-treated rats
D R Snyder, E J Gralla, G L Coleman
Supportive Cancer Therapy
|
July 18, 2008
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis
G Kesava Reddy, Richard J Gralla, Paul J Hesketh
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Vindesine. A review of phase-II trials
R J Gralla, C T Tan, C W Young
Cancer Chemotherapy Reports. Part 3
|
September 1, 1974
Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug
E J Gralla, G L Coleman, A M Jonas
Cancer Treatment Reports
|
December 1, 1982
High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial
L B Tyson, R A Clark, R J Gralla
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 29, 2010
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference
Fausto Roila, Jorn Herrstedt, Richard J Gralla, et al.
Cancer Treatment Reports
|
January 1, 1979
Phase I trial of chlorozotocin
R J Gralla, C T Tan, C W Young
Page
of 33